Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Gyawali, B; de Vries, EGE; Dafni, U; Amaral, T; Barriuso, J; Bogaerts, J; Calles, A; Curigliano, G; Gomez-Roca, C; Kiesewetter, B; Oosting, S; Passaro, A; Pentheroudakis, G; Piccart, M; Roitberg, F; Tabernero, J; Tarazona, N; Trapani, D; Wester, R; Zarkavelis, G; Zielinski, C; Zygoura, P; Cherny, NI.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Esmo Open. 2021; 6(3): 100117-100117 Nº de citas: 52 [doi:10.1016/j.esmoop.2021.100117]

Esteban, E; Exposito, F; Crespo, G; Lambea, J; Pinto, A; Puente, J; Arranz, JA; Redrado, M; Rodriguez-Antona, C; de Andrea, C; Lopez-Brea, M; Redin, E; Rodriguez, A; Serrano, D; Garcia, J; Grande, E; Castellano, D; Calvo, A.

Circulating Levels of the Interferon-gamma-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy

Cancers. 2021; 13(11): Nº de citas: 9 [doi:10.3390/cancers13112849]

Gonzalez-Senac, NM; Mayordomo-Cava, J; Macias-Valle, A; Aldama-Marin, P; Gonzalez, SM; Arnes, MLC; Jimenez-Gomez, LM; Vidan-Astiz, MT; Serra-Rexach, JA.

Colorectal Cancer in Elderly Patients with Surgical Indication: State of the Art, Current Management, Role of Frailty and Benefits of a Geriatric Liaison

International Journal of Environmental Research and Public Health. 2021; 18(11): Nº de citas: 24 [doi:10.3390/ijerph18116072]

Barca-Hernando, M; Munoz-Martin, AJ; Rios-Herranz, E; Garcia-Escobar, I; Beato, C; Font, C; Oncala-Sibajas, E; Revuelta-Rodriguez, A; Areses, MC; Rivas-Jimenez, V; Ballaz-Quincoces, A; Moreno-Santos, MA; Lopez-Saez, JB; Gallego-Gallego, I; Elias-Hernandez, T; Asensio-Cruz, MI; Chasco-Eguilaz, L; Garcia-Gonzalez, G; Estevez-Garcia, P; Marin-Barrera, L; Otero-Candelera, R; Lopez-Ruz, S; Lima-Alvarez, J; Sanchez-Diaz, JM; Real-Dominguez, M; Borrego-Delgado, MC; Marin-Romero, S; Jara-Palomares, L.

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

Cancers. 2021; 13(11): Nº de citas: 6 [doi:10.3390/cancers13112517]

Garcia-Pardo, M; Ortega, L; Fernandez-Acenero, MJ; Alfonso, PG; Martin, M; Munoz, AJ.

Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study

Journal of Gastrointestinal Cancer. 2021; 52(2): 814-818 Nº de citas: 4 [doi:10.1007/s12029-021-00622-0]

Kuemmel, S; Tondini, CA; Abraham, J; Nowecki, Z; Itrych, B; Hitre, E; Karaszewska, B; Juarez-Ramiro, A; Morales-Vasquez, F; Perez-Garcia, JM; Cardona-Huerta, S; Monturus, E; Sequi, M; Restuccia, E; Benyunes, M; Martin, M.

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

BREAST CANCER RESEARCH AND TREATMENT. 2021; 187(2): 467-476 Nº de citas: 10 [doi:10.1007/s10549-021-06145-3]

Aapro, M; Scotte, F; Escobar, Y; Celio, L; Berman, R; Franceschetti, A; Bell, D; Jordan, K.

Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data

ONCOLOGIST. 2021; 26(6): 1073-1082 Nº de citas: 33 [doi:10.1002/onco.13716]

Garcia-Escobar, I; Brozos-Vazquez, E; Abad, DG; Martinez-Marin, V; Pachon, V; Martin, AJM; Canc Thrombosis Sect Spanish.

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(6): 1034-1046 Nº de citas: 4 [doi:10.1007/s12094-020-02506-4]

Garcia-Martin, E; Escudero-Vilaplana, V; Fox, B; Collado-Borrell, R; Marzal-Alfaro, B; Sanchez-Isac, M; Solano-Garzon, ML; del Val, RG; Cano-Gonzalez, JM; de Lucas, NP; Bravo-Guillen, AI; Valero-Salinas, J; Gonzalez-Haba, E; Sanjurjo, M; Martin, M.

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

SUPPORTIVE CARE IN CANCER. 2021; 29(6): 3121-3127 Nº de citas: 6 [doi:10.1007/s00520-020-05828-9]

Escudero-Vilaplana, V; Collado-Borrell, R; Villanueva-Bueno, C; Alvarez, R; Herranz, A; Sanjurjo, M.

Acute pancreatitis in a patient treated with imatinib and gefitinib

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(4): 980-983 Nº de citas: 1 [doi:10.1177/1078155220949639]

Bellmunt, J; Esteban, E; Muro XGD; Sepulveda, JM; Maroto, P; Gallardo, E; Alba AGD; Etxaniz, O; Guix, M; Larriba JLG; Arranz, JA; Redrado, M; Calvo, A.

Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

European Urology Oncology. 2021; 4(3): 502-505 Nº de citas: 4 [doi:10.1016/j.euo.2019.07.014]

Taboada AGM; Lominchar PL; Roman LM; García-Alfonso P; Martin AJM; Rodriguez JAB; Pascual JMA.

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades.

Annals Of Hepato-Biliary-Pancreatic Surgery. 2021; 25(2): 179-191 Nº de citas: 10 [doi:10.14701/ahbps.2021.25.2.179]

Loibl, S; Marme, F; Martin, M; Untch, M; Bonnefoi, H; Kim, SB; Bear, H; McCarthy, N; Olive, MM; Gelmon, K; Garcia-Saenz, J; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Denkert, C; Gnant, M; Makris, A; Koehler, M; Huang-Bartelett, C; Frean, MJL; Colleoni, M; Werutsky, G; Seiler, S; Burchardi, N; Nekljudova, V; von Minckwitz, G.

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(14): 1518-1530 Nº de citas: 249 [doi:10.1200/JCO.20.03639]

Escobar-Alvarez, Y; de Castro-Carpeno, J; Feyjoo, M; Martin-Algarra, S.

Evaluation of patient quality care in Spain in prevention of nausea and vomiting induced by chemotherapy

Journal Of Healthcare Quality Research. 2021; 36(3): 142-149 [doi:10.1016/j.jhqr.2021.01.001]

Verso, M; Munoz, A; Bauersachs, R; Huisman, MV; Mandala, M; Vescovo, G; Becattini, C; Agnelli, G.

Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism

EUROPEAN JOURNAL OF CANCER. 2021; 148: 371-381 Nº de citas: 47 [doi:10.1016/j.ejca.2021.02.026]

Alvarez, YE; Bataller, RD; Altozano, JP; Martinez, SR; Alvarez, AS; Cordellat, AB; Vazquez, EB; Jaime, JC; Escobar, IG; Zambrano, CB.

SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 931-939 Nº de citas: 11 [doi:10.1007/s12094-021-02580-2]

Gomez-Espana, MA; Montes, AF; Garcia-Carbonero, R; Mercade, TM; Maurel, J; Martin, AM; Pazo-Cid, R; Vera, R; Carrato, A; Feliu, J.

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 988-1000 Nº de citas: 37 [doi:10.1007/s12094-021-02573-1]

del Alba, AG; Mendez-Vidal, MJ; Vazquez, S; Castro, E; Climent, MA; Gallardo, E; Gonzalez-Billalabeitia, E; Lorente, D; Maroto, JP; Arranz, JA.

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 969-979 Nº de citas: 22 [doi:10.1007/s12094-021-02561-5]